Cargando…

FDA recommended potent drugs against COVID-19: Insight through molecular docking

Human Coronavirus (COVID-19) is a worldwide pandemic of 2019–20 that was emerged in China in December 2019. More than 37,000deaths with7, 84, 440confirmed cases has been reported from around 200 different countries has been reported till now and the number is increasing every second. The spread is s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gumber, Khushbu, Pomila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832574/ https://www.ncbi.nlm.nih.gov/pubmed/33520672 http://dx.doi.org/10.1016/j.matpr.2020.12.649

Ejemplares similares

Computation screening and molecular docking of FDA approved viral protease inhibitors as a potential drug against COVID-19
por: Absalan, Abdorrahim, et al.
Publicado: (2020)

Repurposing drug molecule against SARS-Cov-2 (COVID-19) through molecular docking and dynamics: a quick approach to pick FDA-approved drugs
por: Farhat, Nabeela, et al.
Publicado: (2021)

Drug Repurposing of FDA Compounds against α-Glucosidase for the Treatment of Type 2 Diabetes: Insights from Molecular Docking and Molecular Dynamics Simulations
por: Rashid, Rebwar Saeed M., et al.
Publicado: (2023)

In silico screening of potent inhibitors against COVID-19 key targets from a library of FDA-approved drugs
por: Elmorsy, Mohammad A., et al.
Publicado: (2021)

Synergy Testing of FDA-Approved Drugs Identifies Potent Drug Combinations against Trypanosoma cruzi
por: Planer, Joseph D., et al.
Publicado: (2014)

Molecular docking analysis of FDA approved drugs with the glycoprotein from Junin and Machupo viruses
por: Malhotra, Himani, et al.
Publicado: (2022)

Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus
por: Odhar, Hasanain Abdulhameed, et al.
Publicado: (2020)

Molecular docking-based screening of methicillin-resistant Staphylococcus aureus FEM proteins with FDA-approved drugs
por: Akkiraju, Anjini Gayatri, et al.
Publicado: (2023)

Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies
por: Hassan, Mubashir, et al.
Publicado: (2022)

FDA and CDC recommend resuming use of Janssen COVID-19 vaccine
Publicado: (2021)

Molecular docking of monkeypox (mpox) virus proteinase with FDA approved lead molecules
por: Arasu, M.Valan, et al.
Publicado: (2023)

Accelerating the repurposing of FDA-approved drugs against coronavirus disease-19 (COVID-19)
por: De Vita, Simona, et al.
Publicado: (2020)

Fluorine-a small magic bullet atom in the drug development: perspective to FDA approved and COVID-19 recommended drugs
por: Chandra, Girish, et al.
Publicado: (2023)

A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection
por: Abo-zeid, Yasmin, et al.
Publicado: (2020)

FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
por: Mostafa, Ahmed, et al.
Publicado: (2020)

Identification of phytocompounds as newer antiviral drugs against COVID-19 through molecular docking and simulation based study
por: Kar, Bipasa, et al.
Publicado: (2022)

Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2
por: Anwaar, Muhammad U., et al.
Publicado: (2022)

Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
por: Kandeel, Mahmoud, et al.
Publicado: (2020)

Response Surface Study on Molecular Docking Simulations of Citalopram and Donepezil as Potent CNS Drugs
por: Alikhani, Radin, et al.
Publicado: (2021)

Exploring Prognostic Biomarkers of Acute Myeloid Leukemia to Determine Its Most Effective Drugs from the FDA-Approved List through Molecular Docking and Dynamic Simulation
por: Alom, Md. Murshid, et al.
Publicado: (2023)

In Silico Study towards Repositioning of FDA-Approved Drug Candidates for Anticoronaviral Therapy: Molecular Docking, Molecular Dynamics and Binding Free Energy Calculations
por: Qayed, Wesam S., et al.
Publicado: (2022)

An Insight into FDA Approved Antibody-Drug Conjugates for Cancer Therapy
por: Tong, Juliana T. W., et al.
Publicado: (2021)

In silico designing and molecular docking of a potent analog against Staphylococcus aureus porphobilinogen synthase
por: Kumar, Pasupuleti Santhosh, et al.
Publicado: (2014)

Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation
por: Cava, Claudia, et al.
Publicado: (2021)

FDA remote evaluation of drug manufacturing during COVID-19
Publicado: (2021)

Potential inhibitors interacting in Neuropilin-1 to develop an adjuvant drug against COVID-19, by molecular docking
por: Vique-Sánchez, José Luis
Publicado: (2021)

Insights into the interaction of potent antimicrobial chalcone triazole analogs with human serum albumin: spectroscopy and molecular docking approaches
por: Yadav, Priyanka, et al.
Publicado: (2019)

Molecular docking and inhibition studies on the interactions of Bacopa monnieri’s potent phytochemicals against pathogenic Staphylococcus aureus
por: Emran, Talha Bin, et al.
Publicado: (2015)

Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil as Highly Potent Inhibitor of T Cell Proliferation
por: Voss, Linda, et al.
Publicado: (2021)

Garcinia cambogia Phenolics as Potent Anti-COVID-19 Agents: Phytochemical Profiling, Biological Activities, and Molecular Docking
por: Aati, Hanan Y., et al.
Publicado: (2022)

Repurposing of FDA-approved drugs against cancer – focus on metastasis
por: Ozsvári, Béla, et al.
Publicado: (2016)

Molecular docking and dynamics simulation analysis of nucleoprotein from the Crimea-Congo hemorrhagic fever virus strain Baghdad-12 with FDA approved drugs
por: Hashim, Ahmed Fadhil, et al.
Publicado: (2022)

Computational Insights and Virtual Screening of Repurposed FDA-Approved Drug Against SARS-CoV-2 Protease
por: Joel, C., et al.
Publicado: (2023)

COVID-19 emergency responders in FDA’s Center for Drug Evaluation and Research
por: Gormley, Lieutenant Commander Andrea, et al.
Publicado: (2020)

EMA and FDA psychiatric drug trial guidelines: assessment of guideline development and trial design recommendations
por: Boesen, Kim, et al.
Publicado: (2021)

The Food and Drug Administration’s (FDA’s) Drug Safety Surveillance During the COVID-19 Pandemic
por: Diak, Ida-Lina, et al.
Publicado: (2022)

Phenolic compounds as promising drug candidates against COVID-19 - an integrated molecular docking and dynamics simulation study
por: Davella, Rakesh, et al.
Publicado: (2022)

Coronavirus disease 2019 drug discovery through molecular docking
por: Singh, Sweta, et al.
Publicado: (2020)

Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system
por: Jeong, Eugene, et al.
Publicado: (2022)

Investigating drug repositioning opportunities in FDA drug labels through topic modeling
por: Bisgin, Halil, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bvhiecc5r7r3ba813a6sid5bc7